fda warning bpc-157 unapproved peptide human use new drug The FDA has issued clear signals on BPC-157: it is not approved for in any form due to potential significant safety risks. This critical fda warning unapproved peptides bpc-157
Description
Injectable intramuscular injection for the treatment of vitamin B 12 deficiency : o In treatment of attack : one ampoule per day or three times a week, intramuscular injection, 10 ampoules in total
* Km values represent acetaldehyde catalytic efficiency and are given in M, and V max values represent the maximal metabolic rate of the enzyme and are given in turnover numbers per minute
Safety and efficacy for this formulation have not been evaluated by the FDA
Some researchers have explored their combined use in laboratory settings, though the majority of published literature examines each compound independently
